Fridbert Jonasson1, Diana E Fisher2, Gudny Eiriksdottir3, Sigurdur Sigurdsson3, Ronald Klein4, Lenore J Launer5, Tamara Harris5, Vilmundur Gudnason6, Mary Frances Cotch2. 1. Department of Ophthalmology, Landspitali University Hospital, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland. Electronic address: fridbert@landspitali.is. 2. Division of Epidemiology and Clinical Applications, National Eye Institute, Bethesda, Maryland. 3. Icelandic Heart Association, Kopavogur, Iceland. 4. Ophthalmology and Visual Sciences, University of Wisconsin Madison, Madison, Wisconsin. 5. Laboratory of Epidemiology, Demography and Biometry, Intramural Research Program, National Institute of Aging, Bethesda, Maryland. 6. Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Icelandic Heart Association, Kopavogur, Iceland.
Abstract
OBJECTIVE: To investigate the incidence and progression of age-related macular degeneration (AMD) and associated risk factors. DESIGN: Population-based, prospective, cohort study. PARTICIPANTS: We included 2868 participants from the Age Gene/Environment Susceptibility-Reykjavik Study with retinal data at baseline and 5-year follow-up. METHODS: Digital macular photographs were graded for presence of AMD. Participants completed a questionnaire and extensive clinical battery. Biomarkers were assessed. Risk factors for AMD were analyzed using multivariate regression analysis with odds ratios (ORs) and 95% CIs. MAIN OUTCOME MEASURES: We assessed AMD, defined as early or late. RESULTS: Among 2196 participants free of AMD at baseline, 14.9% developed incident AMD. In multivariate models, incident AMD was significantly associated with age (OR per year, 1.14; 95% CI, 1.11-1.17), current smoking (OR, 2.07; 95% CI, 1.38-3.11), former smoking (OR, 1.36; 95% CI, 1.04-1.79), plasma high-density lipoprotein (HDL) cholesterol level (OR, 1.62 per mmol/L; 95% CI, 1.19-2.22), and body mass index (BMI; OR, 1.04 per kg/m(2); 95% CI, 1.01-1.07). Among 563 participants with early AMD at baseline, 22.7% progressed to late AMD (11.0% pure geographic atrophy [GA] and 11.7% exudative AMD). On multivariate analyses, age was significantly associated with progression to GA (OR 1.14; 95% CI, 1.07-1.21) and exudative AMD (OR, 1.08; 95% CI, 1.01-1.14). Adjusting for age, female sex was associated with exudative AMD (OR, 2.10; 95% CI, 1.10-3.98) and plasma HDL cholesterol with GA (OR, 2.03 per mmol/L; 95% CI, 1.02-4.05). CONCLUSIONS: By age 85, 57.4% of participants had signs of AMD. Age, smoking, plasma HDL cholesterol, BMI, and female sex are associated with AMD. Elevated HDL cholesterol is associated with GA development.
OBJECTIVE: To investigate the incidence and progression of age-related macular degeneration (AMD) and associated risk factors. DESIGN: Population-based, prospective, cohort study. PARTICIPANTS: We included 2868 participants from the Age Gene/Environment Susceptibility-Reykjavik Study with retinal data at baseline and 5-year follow-up. METHODS: Digital macular photographs were graded for presence of AMD. Participants completed a questionnaire and extensive clinical battery. Biomarkers were assessed. Risk factors for AMD were analyzed using multivariate regression analysis with odds ratios (ORs) and 95% CIs. MAIN OUTCOME MEASURES: We assessed AMD, defined as early or late. RESULTS: Among 2196 participants free of AMD at baseline, 14.9% developed incident AMD. In multivariate models, incident AMD was significantly associated with age (OR per year, 1.14; 95% CI, 1.11-1.17), current smoking (OR, 2.07; 95% CI, 1.38-3.11), former smoking (OR, 1.36; 95% CI, 1.04-1.79), plasma high-density lipoprotein (HDL) cholesterol level (OR, 1.62 per mmol/L; 95% CI, 1.19-2.22), and body mass index (BMI; OR, 1.04 per kg/m(2); 95% CI, 1.01-1.07). Among 563 participants with early AMD at baseline, 22.7% progressed to late AMD (11.0% pure geographic atrophy [GA] and 11.7% exudative AMD). On multivariate analyses, age was significantly associated with progression to GA (OR 1.14; 95% CI, 1.07-1.21) and exudative AMD (OR, 1.08; 95% CI, 1.01-1.14). Adjusting for age, female sex was associated with exudative AMD (OR, 2.10; 95% CI, 1.10-3.98) and plasma HDL cholesterol with GA (OR, 2.03 per mmol/L; 95% CI, 1.02-4.05). CONCLUSIONS: By age 85, 57.4% of participants had signs of AMD. Age, smoking, plasma HDL cholesterol, BMI, and female sex are associated with AMD. Elevated HDL cholesterol is associated with GA development.
Authors: Ronald Klein; Barbara E K Klein; Michael D Knudtson; Stacy M Meuer; Maria Swift; Ronald E Gangnon Journal: Ophthalmology Date: 2007-02 Impact factor: 12.079
Authors: Jie Jin Wang; Elena Rochtchina; Anne J Lee; Ee-Munn Chia; Wayne Smith; Robert G Cumming; Paul Mitchell Journal: Ophthalmology Date: 2007-01 Impact factor: 12.079
Authors: Ronald Klein; Barbara E K Klein; Michael D Knudtson; Tien Yin Wong; Mary Frances Cotch; Kiang Liu; Gregory Burke; Mohammed F Saad; David R Jacobs Journal: Ophthalmology Date: 2006-03 Impact factor: 12.079
Authors: Juan E Grunwald; Maxwell Pistilli; Ebenezer Daniel; Gui-Shuang Ying; Wei Pan; Glenn J Jaffe; Cynthia A Toth; Stephanie A Hagstrom; Maureen G Maguire; Daniel F Martin Journal: Ophthalmology Date: 2016-10-27 Impact factor: 12.079
Authors: Diana E Fisher; Barbara E K Klein; Tien Y Wong; Jerome I Rotter; Xiaohui Li; Sandi Shrager; Gregory L Burke; Ronald Klein; Mary Frances Cotch Journal: Ophthalmology Date: 2016-02-16 Impact factor: 12.079
Authors: Nader Sheibani; Shoujian Wang; Soesiawati R Darjatmoko; Debra L Fisk; Pawan K Shahi; Bikash R Pattnaik; Christine M Sorenson; Reshma Bhowmick; Olga V Volpert; Daniel M Albert; Ignacio Melgar-Asensio; Jack Henkin Journal: Exp Eye Res Date: 2019-09-11 Impact factor: 3.467
Authors: Brandie D Wagner; Jennifer L Patnaik; Alan G Palestine; Ashley A Frazer-Abel; Rebecca Baldermann; V Michael Holers; Marc T Mathias; Naresh Mandava; Anne M Lynch Journal: Ophthalmic Epidemiol Date: 2021-04-08